Topics
January/February 2018 | business Matters fellows' Focus
Entering the Real World
Part two of a two-part series on the final months of retina fellowship.
Christopher M. Aderman, MD; Ferhina S. Ali, MD, MPH; and Katherine Talcott, MD
June 23, 2026
Oculgen Announces First US Patient Enrolled in STAT Trial of OCUL101 for Wet AMD
June 22, 2026
Atsena Doses First Patient in Phase 3 LIGHTHOUSE Trial of Gene Therapy for XLRS
June 19, 2026
Lexitas Pharma Services Named Octane Preferred Advisor
Potential Drug Signals Linked to Wet AMD Identified in Integrative Analysis
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
